Needham & Company LLC upgraded shares of Stryker (NYSE:SYK – Free Report) from a hold rating to a buy rating in a report released on Wednesday morning, Marketbeat Ratings reports. The brokerage currently has $392.00 target price on the medical technology company’s stock. Several other equities analysts have also recently issued reports on SYK. Royal […]